Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Nuvation Bio Inc (NYSE: NUVB)

 
NUVB Technical Analysis
5
As on 19th Nov 2025 NUVB SHARE Price closed @ 7.15 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.59 & Strong Buy for SHORT-TERM with Stoploss of 3.09 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NUVBSHARE Price

Open 4.99 Change Price %
High 7.35 1 Day 2.35 48.96
Low 4.94 1 Week 2.51 54.09
Close 7.15 1 Month 3.43 92.20
Volume 58875445 1 Year 4.35 155.36
52 Week High 5.37 | 52 Week Low 1.66
 
NYSE USA Most Active Stocks
FSR 0.02 0.00%
DDR 15.44 -4.46%
TWTR 53.70 0.66%
SWN 7.11 -0.56%
BACA-U 302.00 0.67%
ENLC 14.12 -0.21%
ABEV 2.47 -2.37%
NOK 6.03 -9.19%
ACHR 7.47 -1.84%
PFE 24.88 -2.24%
 
NYSE USA Top Gainers Stocks
CND-WT 0.05 400.00%
SEMR 11.76 73.96%
WEI 0.44 51.72%
QFTA 10.26 51.33%
MOTV 18.70 50.20%
CORR 0.03 50.00%
NUVB 7.15 48.96%
WE 0.50 42.86%
WE 0.50 42.86%
KUKE 1.39 39.00%
 
NYSE USA Top Losers Stocks
AJX 0.01 -99.67%
AJX 0.01 -99.67%
AJX 0.01 -99.67%
QFTA-WS 0.46 -95.33%
TWND-WS 0.48 -95.12%
CHAA-WS 0.53 -94.56%
PMVC-WS 0.58 -94.10%
PIAI-WS 0.58 -94.09%
PCPC-WS 1.50 -93.83%
FTEV-WS 0.60 -93.81%
 
 
NUVB
Daily Charts		 NUVB
Intraday Charts		 Whats New @
Bazaartrend		 NUVB
Free Analysis
 
NUVB Important Levels Intraday
RESISTANCE11.79
RESISTANCE10.30
RESISTANCE9.38
RESISTANCE8.46
SUPPORT5.84
SUPPORT4.92
SUPPORT4.00
SUPPORT2.51
 
NUVB Forecast November 2025
Share
4th UP Forecast9.6
3rd UP Forecast8.81
2nd UP Forecast8.33
1st UP Forecast7.84
1st DOWN Forecast6.46
2nd DOWN Forecast5.97
3rd DOWN Forecast5.49
4th DOWN Forecast4.7
 
NUVB Weekly Forecast
4th UP Forecast8.11
3rd UP Forecast7.80
2nd UP Forecast7.61
1st UP Forecast7.42
1st DOWN Forecast6.88
2nd DOWN Forecast6.69
3rd DOWN Forecast6.50
4th DOWN Forecast6.19
 
NUVB Forecast2025
4th UP Forecast18.35
3rd UP Forecast14.76
2nd UP Forecast12.54
1st UP Forecast10.32
1st DOWN Forecast3.98
2nd DOWN Forecast1.76
3rd DOWN Forecast-0.46
4th DOWN Forecast-4.05
 
 
NUVB Other Details
Segment EQ
Market Capital 1992494848.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NUVB Address
NUVB
 
NUVB Latest News
 
Your Comments and Response on Nuvation Bio Inc
 
NUVB Business Profile
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting CDK2, CDK4, and CDK6. It is also developing NUV-868, a selective inhibitor of the BET family of epigenetic transcriptional regulators; NUV-569, a differentiated selective inhibitor of the Wee1 kinase; NUV-1182, an adenosine receptor inhibitor; and DDC platform that focuses on targeting an inhibitor of poly ADP ribose polymerase (PARP) to androgen receptor-expressing cancer cells , as well as PARP inhibitor to ER-expressing cancer cells. The company was formerly known as RePharmation Inc. and changed its name to Nuvation Bio Inc. in April 2019. Nuvation Bio Inc. was incorporated in 2018 and is headquartered in New York, New York. Address: 1500 Broadway, New York, NY, United States, 10036
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service